from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3507/PE_PGRS53

LFCtreatmentdescriptionclass of inhibitor

0.813

Amikacinug/mL Amikacintranslation

0.353

Cap5-10ug/mL Capreomycintranslation

0.636

Rox10-50 ug/mL Roxithromycintranslation

0.006

SM2-5 ug/mL Streptomycintranslation

0.850

Tet5-10 ug/mL Tetracyclinetranslation

0.084

Rif0.2-5ug/mL Rifampicintranscription

0.011

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.189

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.136

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.628

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.893

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.748

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.154

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.809

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.484

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.281

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.028

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.141

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.333

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.120

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.020

KCN5-20 ug/mL Potassium cyaniderespiration

1.020

NaN30.2-2 mM Sodium aziderespiration

-0.664

Nigericin50 uM Nigericinrespiration

0.702

TRC10-150 ug/mL Triclosanrespiration

-0.550

TRZ10-25 ug/mL Thioridazinerespiration

3.142

Valinomycin0.5-10 uM Valinomycinrespiration

-0.817

ZnSO42 mM ZnSO4respiration

-0.767

menadione6-10 ug/mL Menadionerespiration

-0.311

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.281

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.107

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.543

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.301

NRP_1Non-replicating persistence stage 1dosRassociated

-0.598

Amp0.2mg/mL AmpicillincellWall

-0.481

Cephalexin20-100 ug/mL CephalexincellWall

-0.241

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.325

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.499

EMB10-20 ug/mL EthambutolcellWall

-0.301

Eta12-40 ug/mL EthionamidecellWall

-0.396

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.409

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.075

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.362

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.670

BZA0.12 mg/mL BenzamidearomaticAmides

0.609

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.180

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.314

H2O24 mM hydrogen peroxideDNAdamaging

0.211

Levo10 ug/mL LevofloxacinDNAdamaging

-0.617

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.455

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.109

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.201

UVUV-irradiationDNAdamaging

-0.384

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.826

Antimycin12.5-50 ug/mL Antimycin A?

-0.735

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.469

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.574

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.816

PA8240.2-2 ug/mL PA-824?

0.894

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.344

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.892

Verapamil50 uM Verapamil?

-0.295

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.287

methoxatin10-20 ug/mL Methoxatin?